Private · Company · Aksjeselskap
SARSIA SEED AS
↳ Brreg · companies
Group financialsNOK
One filed year on record — the trend appears when a second year is published.
Regnskapsregisteret · company_revenue
Job ads on NAV Arbeidsplassen12 MO
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
Public contracts · won → est. expiryaward dates from Doffin/TED · hatched = our estimate, end dates aren't published
0 wins
Doffin/TED · company_tender_wins
Key figuresBrønnøysund
One filed year on record — the trend appears when a second year is published.
Regnskapsregisteret · company_revenue
MoneyNOK
Revenue
—
Operating result
−kr 3.07M
Net result
−kr 35.2M
Total assets
kr 20.9M
Equity
kr 18.3M
one filed year on record · the trend appears when the next year is filed
Regnskapsregisteret · company_financials · FY2024 (company)
Activitylast 24 mo
No job-ad activity on file
totals on file · ads-over-time series not yet in Intelligo
Registry changes
No recorded changes.
NAV + JobStream · company_hiring · Brreg · company_changes
Portfolio · resolved to end-investments
Show flat listOwnership followed through every holdco layer — you land on the operating company, not the shell. Effective stake = product along the chain.
CompanyStakeRevenueResultEmpLast event
Aksjonærregisteret edges · portfolio_edges · latest cap table
■ end-investment — an operating company● pass-through holdcoeffective stake = product along the chain
From the FY2024 accounts
FILEDAccounts filed for FY2024.
AUDITAudited by DELOITTE AS.
BALANCEEquity kr 18.3M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose
Portfolio timeline1 companies
APIM THERAPEUTICS AS — accounts_filed: last_annual_accounts_year2024 -> 2025Registry · 2026-07-27
APIM THERAPEUTICS AS — Audit opinionDeloitte AS issued an unmodified audit opinion stating the financial statements comply with statutory requirements. — oppfyller arsregnsk...Annual report · 2025-12-31
APIM THERAPEUTICS AS — Audit opinionThe audit was carried out in accordance with the International Standards on Auditing. — Vihar gjennomfort revisjonenisamsvarmed Internati...Annual report · 2025-12-31
APIM THERAPEUTICS AS — Staff numbersThe company employed 1.00 man-year during the financial year. — Antall arsverk i regnskapsaretAnnual report · 2025-12-31
APIM THERAPEUTICS AS — RemunerationSalaries were NOK 659 758 in 2025 against NOK 1 175 092 in 2024, with total payroll costs of NOK 770 112. — Lonn 659758.00 1175092.00Annual report · 2025-12-31
APIM THERAPEUTICS AS — Share capitalShare capital consists of 2 265 695 ordinary shares of NOK 1 each, total NOK 2 265 695. — Totalt antall aksjer 2 265 695 100Annual report · 2025-12-31
APIM THERAPEUTICS AS — OwnershipSarsia Seed AS holds 21,41 % and Investor Direkte AS 15,00 % of the shares. — Sarsia Seed AS Investor Direkte AS 485 067 339 860 21,4...Annual report · 2025-12-31
APIM THERAPEUTICS AS — Loan or financing440 772 subscription rights have been issued, each giving the right to subscribe one share at NOK 15, for capital raising to support cont...Annual report · 2025-12-31
APIM THERAPEUTICS AS — ImpairmentNo write-down of financial assets in 2025, against NOK 33 540 409 in 2024. — Nedskrivning av finansielle eiendeler 0 33 540 409Annual report · 2025-12-31
APIM THERAPEUTICS AS — Capitalised R&DOwn research and development costs are expensed as incurred, not capitalised. — Egneforsknings-og utviklingskostnaderkostnadsforesIopende.Annual report · 2025-12-31
APIM THERAPEUTICS AS — ImpairmentPatents constituting the platform technology are carried at cost and not amortised, but the book value is tested for indications of impai...Annual report · 2025-12-31
APIM THERAPEUTICS AS — Deferred taxNo deferred tax asset is recognised; deferred tax at 22 % is calculated to zero as tax-reducing differences cannot be offset. — Utsatt sk...Annual report · 2025-12-31
APIM THERAPEUTICS AS — OtherWithheld payroll tax exceeded the tax-withholding account balance at year end; the remainder was deposited early in January 2026. — Restb...Annual report · 2025-12-31
APIM THERAPEUTICS AS — OtherThe company's business is development, production and marketing/sale of pharmaceutical products, and it is located in Trondheim. — samt a...Annual report · 2025-12-31
APIM THERAPEUTICS AS — STIFTELSEN UNIVERSITETSFORSKNING BERGEN acquired 6.5 pctNew owner · 2025-12-31
APIM THERAPEUTICS AS — NORSK INNOVASJONSKAPITAL III AS exited (held 15.5 pct)Owner exit · 2023-12-31
APIM THERAPEUTICS AS — INVESTINOR AS exited (held 6.3 pct)Owner exit · 2022-12-31
APIM THERAPEUTICS AS — INVESTINOR AS acquired 6.3 pctNew owner · 2021-12-31
Skiwo · company_events
Timelineall sources
SARSIA DEVELOPMENT AS exited (held 8.7 pct)Owner exit · 2025-12-31
Skiwo · company_events
Tenders0 wins · 0 losses
No recorded tender wins.
Relevant open tenders — matched NACE 64.312 ↔ CPV
subscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-03
People0 roles
No registered roles.
registered roles only · website-employee lookup awaits the crawler
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
Structure
Owned by ↑ · top 10
EQUINOR VENTURES AS
23.2%SARSIA MANAGEMENT AS
20.6%TROND MOHN FORSKNINGSSTIFTELSE
12.8%EVINY AS
11.6%STIFTELSEN UNIVERSITETSFORSKNING BERGEN
10.1%SPAREBANKEN NORGE
10.0%DNB BANK ASA
5.3%L. MELTZERS UNIVERSITETSSTIFTELSE
1.5%VIKEN SHIPPING AS
1.2%BERGENS TIDENDE AS
0.9%Aksjonærregisteret · company_ownership · 2025 · both directions
LocationBergen
Bergen
municipality only · street address + coordinates not yet in Intelligo
Brreg · registered municipality